Does ILOPROST Cause Lung neoplasm malignant? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Lung neoplasm malignant have been filed in association with ILOPROST (AURLUMYN). This represents 0.3% of all adverse event reports for ILOPROST.
14
Reports of Lung neoplasm malignant with ILOPROST
0.3%
of all ILOPROST reports
10
Deaths
8
Hospitalizations
How Dangerous Is Lung neoplasm malignant From ILOPROST?
Of the 14 reports, 10 (71.4%) resulted in death, 8 (57.1%) required hospitalization, and 1 (7.1%) were considered life-threatening.
Is Lung neoplasm malignant Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ILOPROST. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does ILOPROST Cause?
Death (1,369)
Dyspnoea (662)
Headache (353)
Cough (284)
Pulmonary arterial hypertension (284)
Hospitalisation (281)
Fatigue (280)
Dizziness (225)
Pneumonia (224)
Pulmonary hypertension (216)
What Other Drugs Cause Lung neoplasm malignant?
RANITIDINE (15,214)
ADALIMUMAB (698)
TIOTROPIUM (637)
ETANERCEPT (612)
METHOTREXATE (522)
CLOZAPINE (440)
APIXABAN (411)
ALBUTEROL (403)
INFLIXIMAB (379)
BUDESONIDE\FORMOTEROL (353)
Which ILOPROST Alternatives Have Lower Lung neoplasm malignant Risk?
ILOPROST vs IMATINIB
ILOPROST vs IMBRUVICA
ILOPROST vs IMDEVIMAB
ILOPROST vs IMEGLIMIN
ILOPROST vs IMETELSTAT